Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
5 May, 26
WCO-IOF-ESCEO 2026
Key sessions focusing on osteoporosis therapy presented at the 26th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Prague, Czech Republic.
5 May, 26
WCO-IOF-ESCEO 2026
Key sessions on diabetes and bone health in osteoporotic patients presented at the 26th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Prague, Czech Republic.
21 May, 26
Endocr Pract.
- Amongst 406 hyperglycemic crisis patients [303 diabetic ketoacidosis (DKA), 103 hyperosmolar hyperglycemic state (HHS)], 14.8% had acute pancreatitis (AP), more frequent in DKA (17.5%) vs HHS (6.8%)
- Higher BMI, abdominal pain, shock, high γ-GTP, & hypertriglyceridemia predicted AP
- Alcohol use, T2DM, abdominal pain, shock, & γ-GTP predicted AP in DKA
- AP increased ICU admission but not hospital stay or mortality.
18 May, 26
Diabetic Med.
- As per the meta-analysis of 22 studies (13074868 subjects; 2644443 with T2DM), T2DM raised fracture risk by 25%
- Risk was higher for lower limb fractures (HR 1.43), upper limb (HR 1.29), osteoporotic/fragility (HR 1.14), & unspecified fractures (HR 1.25)
- The link was robust in women & in those with longer T2DM duration
- Targeted fracture prevention strategies & focused risk assessment is critical in T2DM patients.
15 May, 26
Clin. Microbiol. Inf...
- Short course (2–5 d) antibiotics similar to ≥7 d for relapse and reinfection.
- No significant difference in clinical or bacteriological cure rates.
- Adverse events comparable between short and long courses.
- Shorter therapy appears effective/safe; more data needed in infants/recurrent UTI.
15 May, 26
BMJ Diabetes Open Re...
- Amongst 1,208 patients with T2DM & hypertension (mean age 58.3; 60.1% male), 42.5% had fibrosis-4 (FIB-4) index > 1.3
- Elevated FIB-4 was independently associated with KDIGO 3–4 (high/very high risk) (OR 1.57, p=0.008) & CKD (OR 1.51, p=0.004)
- Even within KDIGO low-risk groups, high FIB-4 correlated with vascular comorbidities (p<0.01)
- FIB-4 may complement KDIGO for early CKD risk stratification.
Featured

13 May, 26

13 May, 26

5 May, 26
















